Jan Marini Skin Research Marks 20 Years of Innovation - 13 WTHR Indianapolis

Jan Marini Skin Research Marks 20 Years of Innovation

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE:

Company Brings Industry Firsts and Proprietary Technology to Market with Results, Innovation and Commitment

San Jose, California (PRWEB) July 10, 2014

In an over-saturated beauty market, upwards of 80 percent of brands fail as they lack differentiation from competitors, according to Ernst & Young as cited by The Beauty Company. Against these odds, after 20 years, Jan Marini Skin Research (JMSR) continues to distinguish itself as a recognized leader in the professional skincare industry through its combined focus on results, new product innovation and its commitment to clinical and medical validation.

Through new product research and development the company has a significant portfolio of proprietary formulas and industry firsts including, but not limited to, topical TGF beta-1 and other growth factors, cutting edge acne and anti-aging breakthroughs, the first lipid soluble form of vitamin C, the first cosmetic eyelash enhancer and multiple patented technologies. To further ensure their commitment to results, the JMSR team works closely with leading independent physicians to verify product efficacy through independent clinical studies. Most recently, Robert Weiss, MD conducted a study on new patented growth factor and peptide anti-aging formulation and Leslie Bauman, MD completed a consumer preference study comparing JMSRs C-ESTA® Serum and Marini Physical Protectant to two leading competitors with significantly positive findings.

Physicians rely on JMSR products and innovations for skin care results. Lee Ann M. Klausner, double Board Certified Plastic Surgeon in Manhattan states, Jan Marini Skin Researchs products consistently outshine their competitors. I was introduced to the line eight years ago and have recommended it to all of my patients since. Ive seen the impact that JMSRs products, particularly the Skin Care Management System, have on my clients and feel they are superior to anything else on the market, to-date.

Margaret Weiss, MD, FAAD says, Jan Marini brought her experience from the earliest years of science with alpha-hydroxy acids, to build a successful skin-care company based on science. Our patients have benefited from the products and evolving technology for many years.

Karen Yeager, office manager at Mid-South Dermatology and Skin Cancer Center states, I have been a partner with JMSR for the past three years and I feel it was one of the best decisions I have made in the 12 years that I have been in this business. I have never worked with a company as amazing as Jan Marini Skin Research.

An icon in the skincare market, CEO, Jan Marini continues to make her mark on the industry. Our mission is to consistently deliver clinically and medically proven products that deliver solutions across a broad spectrum of concerns, says Marini. We have achieved tremendous recognition and respect in the medical community by staying ahead of cutting edge research and development. JMSR has established an intensely loyal following because our products truly produce remarkable benefits.

In a constantly evolving market, the JMSR team continues to raise the technology bar in skincare with a timeline of significant initiatives and industry firsts. True to form, JMSR has multiple new products in development and clinical validation for release in 2014 and beyond. To mark their 20th anniversary, JMSR is hosting 20 Days of Giveaways on their official Facebook page, https://www.facebook.com/JanMariniSkinResearch. Two grand prize winners will have the opportunity to win a years worth of Jan Marini Skin Research products, valued at over $1500. For additional information or to find a local reseller, please visit http://www.janmarini.com.

References:
1.    http://www.thebeautycompany.co/downloads/Beyer_BeautyNumbers.pdf - June 2012

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/07/prweb12006270.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

Powered by WorldNow